Anteris Technologies has appointed Brent Moen as its new chief financial officer, enhancing its financial leadership. This appointment aligns with the company's advancements in its structural heart program, particularly the DurAVR transcatheter heart valve.
Company Information
Company
Anteris Technologies
Location
860 Blue Gentian Rd
Toowong, Queensland, Australia
About
Anteris® Technologies is a global structural heart company dedicated to revolutionizing cardiac care. Our mission is to forge new frontiers in cardiac care by pioneering science-driven and measurable advancements to restore heart valve patients to healthy function. Transcatheter Aortic Valve Replacement (TAVR) technologies were originally designed for older, high-risk patients. Today, younger, more active patients need a better solution that will not just open and close but restore healthy heart function. We sought to restore healthy blood flow patterns by creating the world’s first biomimetic TAVR valve, DurAVR® THV. This cutting-edge valve, incorporating our proprietary ADAPT® anti-calcification technology, is designed to mimic the natural function of a healthy heart valve.
Don't miss Anteris Technologies's next move
Get an email the moment Anteris Technologies changes its leadership, hires an exec, or expands, usually minutes after it happens.
ToowongManufacturingBiotechnologyHealth CareMedicalMedical Devicemedical devices